Myasthenia gravis: further electrophysiological and ultrastructural analysis of transmission failure in the mouse passive transfer model
- PMID: 210263
- PMCID: PMC1083392
- DOI: 10.1136/jnnp.41.8.746
Myasthenia gravis: further electrophysiological and ultrastructural analysis of transmission failure in the mouse passive transfer model
Abstract
Using the mouse passive transfer model the mean amplitude of miniature endplate potentials and endplate potentials of mice treated with myasthenic immunoglobulins was markedly decreased. Miniature endplate potential frequency and quantum content of endplate potentials were normal, arguing against a major presynaptic disarrangement. Under electron-microscopy no gross structural alterations of endplates were demonstrated. It is concluded that the mouse passive transfer model closely resembles human myasthenia gravis of recent onset.
Similar articles
-
Presynaptic function modified by acetylcholine-receptor interaction in experimental autoimmune myasthenia gravis.J Neurol Sci. 1984 Nov-Dec;66(2-3):245-53. doi: 10.1016/0022-510x(84)90013-3. J Neurol Sci. 1984. PMID: 6099402
-
Morphologic and immunopathologic findings in myasthenia gravis and in congenital myasthenic syndromes.J Neurol Neurosurg Psychiatry. 1980 Jul;43(7):577-89. doi: 10.1136/jnnp.43.7.577. J Neurol Neurosurg Psychiatry. 1980. PMID: 6249893 Free PMC article.
-
Passive transfer of the Lambert-Eaton myasthenic syndrome: neuromuscular transmission in mice injected with plasma.Muscle Nerve. 1985 Feb;8(2):162-72. doi: 10.1002/mus.880080213. Muscle Nerve. 1985. PMID: 2997605
-
The pathogenesis of myasthenia gravis.J Neurochem. 1978 Jul;31(1):5-11. doi: 10.1111/j.1471-4159.1978.tb12426.x. J Neurochem. 1978. PMID: 209148 Review. No abstract available.
-
Short review of progress in experimental myasthenia gravis, bearing on the pathogenesis of myasthenia gravis.Prog Brain Res. 1979;49:459-63. doi: 10.1016/s0079-6123(08)64658-0. Prog Brain Res. 1979. PMID: 390612 Review. No abstract available.
Cited by
-
Passively transferred myasthenia gravis: protection of mouse endplates by Fab fragments from human myasthenic IgG.J Neurol Neurosurg Psychiatry. 1980 Sep;43(9):836-42. doi: 10.1136/jnnp.43.9.836. J Neurol Neurosurg Psychiatry. 1980. PMID: 6252294 Free PMC article.
-
[Demonstration of acetylcholine receptor antibodies in the serum of myasthenia gravis patients applying affinity chromatographically purified human acetylcholine receptor preparations (author's transl)].Klin Wochenschr. 1979 Sep 3;57(17):875-81. doi: 10.1007/BF01477026. Klin Wochenschr. 1979. PMID: 502355 German.
-
Induction of the morphologic changes of both acute and chronic experimental myasthenia by monoclonal antibody directed against acetylcholine receptor.Acta Neuropathol. 1984;63(2):131-43. doi: 10.1007/BF00697195. Acta Neuropathol. 1984. PMID: 6610275
-
Complement Inhibitor Therapy for Myasthenia Gravis.Front Immunol. 2020 Jun 3;11:917. doi: 10.3389/fimmu.2020.00917. eCollection 2020. Front Immunol. 2020. PMID: 32582144 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources